MPAM
TMO icon

Murphy Pohlad Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Murphy Pohlad Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.19M Sell
2,367
-200
-8% -$96K 0.41% 71
2026
Q1 		$1.26M Hold
2,567
– – 0.45% 62
2025
Q4 		$1.49M Hold
2,567
– – 0.57% 59
2025
Q3 		$1.25M Buy
2,567
+25
+1% +$11.6K 0.49% 61
2025
Q2 		$1.03M Buy
+2,542
New +$1.06M 0.44% 64

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Murphy Pohlad Asset Management's TMO Position: Q2 2026 in Review

Murphy Pohlad Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 7.8% in Q2 2026, selling an estimated $96K and leaving 2,367 shares worth $1.19M. The position accounts for 0.41% of the portfolio, ranked #71.

Murphy Pohlad Asset Management first reported a position in TMO in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.49M in Q4 2025. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Murphy Pohlad Asset Management held 2,367 shares of Thermo Fisher Scientific worth $1.19M as of Q2 2026.
  • Murphy Pohlad Asset Management sold 200 Thermo Fisher Scientific shares in Q2 2026, an estimated $96K.
  • Thermo Fisher Scientific made up 0.41% of Murphy Pohlad Asset Management's portfolio in Q2 2026, its #71 holding.
  • Murphy Pohlad Asset Management first reported a position in Thermo Fisher Scientific in Q2 2025 and has held it in 5 quarters since.
  • Murphy Pohlad Asset Management's Thermo Fisher Scientific position peaked at $1.49M in Q4 2025.
  • 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Murphy Pohlad Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.